LONDON, UK – Ingenion Medical Limited announces that Tim Maloney has joined the senior management of the company as Commercial Director to support the pre-commercialization activities and launch of its ground-breaking CymActive SoftValve device to treat non-neurogenic chronic urinary retention in men. The CymActive SoftValve is the first in a range of devices from Ingenion to treat chronic urinary control issues.
Ed Cappabianca, CEO of Ingenion Medical, said: “Ingenion is pleased to announce the appointment of Tim Maloney as our Commercial Director. Tim joins our team with more than 25-years in sales and marketing, business development and commercial roles in medical device companies from start-ups to public companies. Tim worked in both marketing and sales at Bard before joining Biocompatibles working across the globe. Working with a wide distributor network to launch different coronary stent ranges including drug-eluting stents. Following the sale of the stent ranges to Abbott, Tim continued with Biocompatibles where he worked with a new distribution network to launch world-first embolization products including drug-eluting beads for liver cancer.
““Tim’s experience with successful commercial launches and rapid sales growth of multiple medical devices is a valuable asset for Ingenion. Tim’s commercial experience with distributor selection, appointment and management is exactly what Ingenion needs as we approach CE Mark and launch.
“Tim will develop commercial relationships with national and regional distributors for the sales & marketing of CymActive SoftValve. The product’s benefits deserve to be in as many countries as possible.”
Tim Maloney, Commercial Director, commented: “I am looking forward to building a distributor network to make CymActive’s benefits available to as many patients as possible. CymActive’s ability to significantly improve the mobility and quality of life for patients who need it make CymActive one of those special products that’s a joy to have the privilege of working with.”
Visit www.ingenionmedical.co.uk for more information.
Contact: Edward Cappabianca, Chief Executive Officer
E-mail: info@ingenionmedical.co.uk
About Ingenion Medical Limited:
Privately held, UK-based Ingenion Medical Limited develops, manufactures, and commercializes a family of products for chronic urinary retention and incontinence patients. CymActive™, its lead product, is a novel urinary catheter with a novel, magnetically controlled valve which can remain in-dwelling for up to 30 days, designed to deliver a dramatic quality of life improvement versus legacy solutions that often requires multiple catheters in a single day or long-term indwelling catheters, which are a common cause of infection.
Visit us at: ingenionmedical.co.uk
#urology
#medical devices
#medical device distribution
